A Phase II study of S-1 plus oral leucovorin in heavily treated metastatic colorectal cancer patients

PURPOSE: Fewer treatment options are available for refractory metastatic colorectal cancer (mCRC). In early trials, S-1 monotherapy was effective for mCRC patients after chemotherapy failure and its combination with oral leucovorin therapy offers promising results in untreated mCRC. Hence, we conduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Hung-Chih, Chou, Wen-Chi, Kuan, Feng-Che, Lee, Kuan-Der, Rau, Kun-Ming, Huang, Jen-Seng, Yang, Tsai-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252780/
https://www.ncbi.nlm.nih.gov/pubmed/30538555
http://dx.doi.org/10.2147/CMAR.S179345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252780/
https://www.ncbi.nlm.nih.gov/pubmed/30538555
http://dx.doi.org/10.2147/CMAR.S179345

Ejemplares similares